https://www.selleckchem.com/pr....oducts/protoporphyri
BACKGROUND Biologic therapies are a key component of modern medicine, especially in the treatment of chronic conditions and in particular immune-mediated diseases. Biosimilars are molecularly highly similar variants of biologic therapies approved after patent expiration of the original product. OBJECTIVES To provide an overview of the emerging role of biosimilars and present data with respect to efficacy and safety. CURRENT DATA Since the approval of human insulin as the first biologic therapy, over 150 biologic therapeutics h
Gefällt mir
Kommentar
Teilen
